These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
218 related articles for article (PubMed ID: 22826990)
1. The clinical significance of antibody determination to cyclic citrullinated peptides in systemic sclerosis. Stamenković B; Stanković A; Dimić A; Damjanov N; Nedović J; Stojanović S; Savić V; Djordjević D Srp Arh Celok Lek; 2012; 140(5-6):350-4. PubMed ID: 22826990 [TBL] [Abstract][Full Text] [Related]
2. Alveolar bone loss is associated with circulating anti-citrullinated protein antibody (ACPA) in patients with rheumatoid arthritis. Gonzalez SM; Payne JB; Yu F; Thiele GM; Erickson AR; Johnson PG; Schmid MJ; Cannon GW; Kerr GS; Reimold AM; Sokolove J; Robinson WH; Mikuls TR J Periodontol; 2015 Feb; 86(2):222-31. PubMed ID: 25299390 [TBL] [Abstract][Full Text] [Related]
3. Evaluating hand in systemic sclerosis. Arslan Tas D; Erken E; Sakalli H; Yucel AE Rheumatol Int; 2012 Nov; 32(11):3581-6. PubMed ID: 22090005 [TBL] [Abstract][Full Text] [Related]
4. Anti-citrullinated peptide antibodies and the progression of radiographic joint erosions in patients with early rheumatoid arthritis treated with FIN-RACo combination and single disease-modifying antirheumatic drug strategies. Mustila A; Korpela M; Haapala AM; Kautiainen H; Laasonen L; Möttönen T; Leirisalo-Repo M; Ilonen J; Järvenpää S; Luukkainen R; Hannonen P Clin Exp Rheumatol; 2011; 29(3):500-5. PubMed ID: 21640044 [TBL] [Abstract][Full Text] [Related]
5. Significance of combined anti-CCP antibodies and rheumatoid factor in a New Zealand cohort of patients with systemic sclerosis. Kamalaksha S; White DHN; Solanki KK Int J Rheum Dis; 2018 Jul; 21(7):1430-1435. PubMed ID: 29968328 [TBL] [Abstract][Full Text] [Related]
6. The association between anti-carbamylated protein (anti-CarP) antibodies and radiographic progression in early rheumatoid arthritis: a study exploring replication and the added value to ACPA and rheumatoid factor. Ajeganova S; van Steenbergen HW; Verheul MK; Forslind K; Hafström I; Toes RE; Huizinga TW; Svensson B; Trouw LA; van der Helm-van Mil AH Ann Rheum Dis; 2017 Jan; 76(1):112-118. PubMed ID: 27117699 [TBL] [Abstract][Full Text] [Related]
7. Overlap between systemic sclerosis and rheumatoid arthritis: a distinct clinical entity? Horimoto AM; da Costa IP Rev Bras Reumatol Engl Ed; 2016; 56(4):287-98. PubMed ID: 27476621 [TBL] [Abstract][Full Text] [Related]
8. Additive effect of anti-citrullinated protein antibodies and rheumatoid factor on bone erosions in patients with RA. Hecht C; Englbrecht M; Rech J; Schmidt S; Araujo E; Engelke K; Finzel S; Schett G Ann Rheum Dis; 2015 Dec; 74(12):2151-6. PubMed ID: 25115448 [TBL] [Abstract][Full Text] [Related]
9. Use of antibodies recognizing cyclic citrullinated peptide in the differential diagnosis of joint involvement in systemic sclerosis. Ingegnoli F; Galbiati V; Zeni S; Meani L; Zahalkova L; Lubatti C; Soldi A; Paresce E; Murgo A; Crapanzano C; Fantini F Clin Rheumatol; 2007 Apr; 26(4):510-4. PubMed ID: 16670827 [TBL] [Abstract][Full Text] [Related]
10. Characterization of cumulative joint damage patterns in patients with rheumatoid arthritis: a clinical, serological, and gene polymorphism perspective. Alarcon RT; Fernandes Ada R; Laurindo IM; Bértolo MB; Pinheiro GC; Andrade LE J Rheumatol; 2015 Mar; 42(3):405-12. PubMed ID: 25641888 [TBL] [Abstract][Full Text] [Related]
11. A study of erosive phenotypes in lupus arthritis using magnetic resonance imaging and anti-citrullinated protein antibody, anti-RA33 and RF autoantibody status. Ball EM; Tan AL; Fukuba E; McGonagle D; Grey A; Steiner G; Bell AL; Rooney MR Rheumatology (Oxford); 2014 Oct; 53(10):1835-43. PubMed ID: 24850876 [TBL] [Abstract][Full Text] [Related]
12. Anti-citrullinated peptides antibodies in systemic sclerosis: Meta-analysis of frequency and meaning. Laustriat G; Ruyssen-Witrand A; Constantin A; Barnetche T; Adoue D; Cantagrel A; Degboé Y Joint Bone Spine; 2018 Mar; 85(2):147-153. PubMed ID: 29183860 [TBL] [Abstract][Full Text] [Related]
13. SPP1 rs9138 variant contributes to the severity of radiological damage in anti-citrullinated protein autoantibody-negative rheumatoid arthritis. Juge PA; van Steenbergen HW; Constantin A; Tobon GJ; Schaeverbeke T; Gazal S; Combe B; Devauchelle-Pensec V; Nigon D; van der Helm-van Mil AH; Dieude P Ann Rheum Dis; 2014 Oct; 73(10):1840-3. PubMed ID: 24936586 [TBL] [Abstract][Full Text] [Related]
14. Anti-hnRNP and other autoantibodies in systemic sclerosis with joint involvement. Generini S; Steiner G; Miniati I; Conforti ML; Guiducci S; Skriner K; Kaloudi O; Giacomelli R; Smolen J; Matucci-Cerinic M Rheumatology (Oxford); 2009 Aug; 48(8):920-5. PubMed ID: 19483090 [TBL] [Abstract][Full Text] [Related]
15. Anti-citrullinated protein antibodies and high levels of rheumatoid factor are associated with systemic bone loss in patients with early untreated rheumatoid arthritis. Bugatti S; Bogliolo L; Vitolo B; Manzo A; Montecucco C; Caporali R Arthritis Res Ther; 2016 Oct; 18(1):226. PubMed ID: 27716332 [TBL] [Abstract][Full Text] [Related]
16. MRI-detected osteitis is not associated with the presence or level of ACPA alone, but with the combined presence of ACPA and RF. Boeters DM; Nieuwenhuis WP; Verheul MK; Newsum EC; Reijnierse M; Toes RE; Trouw LA; van der Helm-van Mil AH Arthritis Res Ther; 2016 Aug; 18():179. PubMed ID: 27485323 [TBL] [Abstract][Full Text] [Related]
17. Association of the Presence of Anti-Carbamylated Protein Antibodies in Early Arthritis With a Poorer Clinical and Radiologic Outcome: Data From the French ESPOIR Cohort. Truchetet ME; Dublanc S; Barnetche T; Vittecoq O; Mariette X; Richez C; Blanco P; Mahler M; Contin-Bordes C; Schaeverbeke T; Arthritis Rheumatol; 2017 Dec; 69(12):2292-2302. PubMed ID: 28853240 [TBL] [Abstract][Full Text] [Related]
18. Ultrasonographic features of the hand and wrist in systemic sclerosis. Cuomo G; Zappia M; Abignano G; Iudici M; Rotondo A; Valentini G Rheumatology (Oxford); 2009 Nov; 48(11):1414-7. PubMed ID: 19729497 [TBL] [Abstract][Full Text] [Related]
19. Association of cumulative anti-cyclic citrullinated protein antibodies with radiographic progression in patients with rheumatoid arthritis. Joo YB; Park YJ; Park KS; Kim KJ Clin Rheumatol; 2019 Sep; 38(9):2423-2432. PubMed ID: 31049760 [TBL] [Abstract][Full Text] [Related]
20. Value of anti-modified citrullinated vimentin and third-generation anti-cyclic citrullinated peptide compared with second-generation anti-cyclic citrullinated peptide and rheumatoid factor in predicting disease outcome in undifferentiated arthritis and rheumatoid arthritis. van der Linden MP; van der Woude D; Ioan-Facsinay A; Levarht EW; Stoeken-Rijsbergen G; Huizinga TW; Toes RE; van der Helm-van Mil AH Arthritis Rheum; 2009 Aug; 60(8):2232-41. PubMed ID: 19644872 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]